S Li, J Chen, X Li, D Shi - European Journal of Medicinal Chemistry, 2023 - Elsevier
Overexpression of eIF4E is common in patients with various solid tumors and hematologic
cancers. As a potential anti-cancer target, eIF4E has attracted extensive attention from …